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> A JEWEL 
IN THE 
I Gray Map 
A four-year study at the Institute will help to identify and treat 
patients who are at risk of bone loss in the upper and lower 
jaws. These histograms and color-enhanced images distinguish 
between healthy peridontal bone (depicted as a normal bell- 
shaped curve and a homogeneous distribution of color levels) 
and bone resorption (distortion in plot curve and extreme vari- 
ance in brightness levels). For more information, turn to page 6. 
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.A WOMAN'S HEALTH ISSUE 
The combination of aerospace technology and digital 
imaging may help to establish a link between osteoporosis 
and peridontal bone loss in postmenopausal women. 
.^..AJEV^elN.[niE.MAi™G  
Positron emission tomography and a man-made version 
of one of the body's proteins offer a bright spot in the 
diagnosis and treatment of prostate cancer. 
IMAGING CENTER 
Construction of the Institute's research center moves 
steadily toward its scheduled mid-1994 completion date. 
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ON THE COVER: 
Just as some breast cancer cells are receptive to the hormone estrogen, 
prostate cancer cells may carry receptors for somatostatin, a natural 
protein. In her lab at Mallinckrodt Institute, Dr. Carolyn Anderson hopes 
to synthesize somatostatin for use in prostate cancer research. 






After a 15-year absence 
from the Institute, William E. 
Powers, M.D., a recognized 
authority in treatment tech- 
niques for carcinoma of the 
uterine cervix and preopera- 
tive radiation therapy for 
head-and-neck tumors, pre- 
sented the Probstein Oncol- 
ogy Lecture on September 10. 
Speaking on "Bone Metas- 
tases: Fallacies, Dogma, and 
Reason," Powers peppered his 
talk with witty observations 
(including a suggested list of 
little known punctuations and 
terms for use in scientific 
papers) while driving home 
the clinical facts about bone 
metastases. 
Powers pointed out that 
bone metastases occur in 
100,000 new patients each 
year. At least one-fifth of 
patients who die of cancer 
William E. Powers, M.D., 
experience clinical bone 
metastases, and one-third of 
those patients develop frac- 
tures or cord compression that 
produce massive dysfunction. 
He believes that radiation ther- 
apy is the least expensive and 
most effective local 
chemotherapeutic agent 
known, and that any patient 
with clinical lesion metastases 
should be treated concurrently 
to systemic therapy with local 
high dose radiation therapy. 
Powers, a 1993 recipient 
of the prestigious Gold Medal 
Award presented by the Ameri- 
can College of Radiology, is a 
former director of the MIR 
Radiation Oncology Center. 
In the late 1960s, while on staff 
at the Institute, he recognized 
the necessity of shielding sur- 
rounding normal tissue from 
the high doses of radiation 
required to destroy tumors. 
His design for blocks made of 
an alloy called Cerrobend is 
used in radiation oncology cen- 
ters nationwide. In 1965, work- 
ing with Washington University 
computer scientists, Powers 
was instrumental in developing 
a computer system dedicated 
to radiation treatment plan- 
ning. In 1978, he was 
appointed chairman of the 
Department of Radiation 
Oncology at Wayne State 
University School of Medicine 
in Detroit. 
The Probstein Oncology 
Lecture was established in 
1985 in honor of Carlos A. 
Perez, M.D., director of the 
MIR Radiation Oncology Cen- 
ter, and William Fair, M.D., 
former head of urology in 
Washington University's 





As the first MIR recipi- 
ent of the Robert Wood 
Johnson Clinical Scholar- 
ship, Howard Forman, M.D., 
fourth-year resident in diag- 
nostic radiology, will begin 
health services research in 
1994 at the University of 
Pennsylvania's Wharton 
School of Business. 
The scholarship is an 
unusual honor for a radiolo- 
gist. During its 20-year his- 
tory, past recipients have 
generally been clinicians, a 
number of whom have gone 
on to chair internal medicine 
departments at top U.S. med- 
ical centers. Many of the 
physicians who are members 
of First Lady Hillary Rodham 
Clinton's Task Force for 
Health Care Reform also 
received the award. The 
scholarship is sponsored by 
the Robert Wood Johnson 
Foundation, the United 
States' largest privately- 
funded health-care research 
foundation. 
During his two-year pro- 
gram, Forman will focus his 
studies on the technology 
assessment and cost-effec- 
tiveness of health care. 
According to Forman, "In 
order to have an excellent 
health-care program, you not 
only need the technology 
and science but also the abil- 





At the American College 
of Radiology (ACR) Annual 
Meeting in September, three 
MIR faculty members stood 
among the 112 outstanding 
clinicians and scientists 
nationwide who were desig- 
nated as ACR fellows: 
Venkata R. Devineni, M.D.; 
Joseph R. Simpson, Ph.D., 
M.D.; and Michael W. Van- 
nier, M.D. The ACR annually 
recognizes those radiologists, 
radiation oncologists, and 
radiological physicists who 
make significant scientific or 
clinical research contribu- 
tions or literary contributions 
in the field of radiology. 
Devineni, an associate 
professor of radiology, Radia- 
tion Oncology Center, is clini- 
cal chief of radiation oncol- 
ogy at DePaul Hospital. He 
was chief resident during his 
training at Emory University 
and completed a fellowship at 
the Institute. Since joining the 
MIR faculty in 1980, Devi- 
neni's primary interest has 
been in clinical radiation 
oncology, specifically head- 
and-neck oncology. 
Simpson, an associate 
professor of radiology, Radia- 
tion Oncology Center, joined 
the MIR faculty in 1978 after 
completing a residency in 
radiation oncology at the Uni- 
versity of Wisconsin Hospital, 
Madison. During his training, 
he was chief resident, 1977 to 
1978, and was named an 
American Cancer Society 
Clinical Fellow. At the Insti- 
tute, Simpson has focused his 
research on treatment tech- 
niques of central nervous sys- 
tem tumors, including 
stereotactic external beam 
irradiation and 3-D treatment 
planning. 
















Vannier, professor of 
radiology, director of the 
Division of Radiology 
Research, is a pioneer in the 
clinical application of 3-D 
imaging. He works closely 
with surgical collaborators to 
identify and develop com- 
puter aids for diagnosis and 
treatment. After completing 
a residency in diagnostic radi- 
ology at MIR, Vannier joined 
the faculty in 1982. 
An additional honor for 
the Institute is the renaming 
of MIR Director Ronald G. 
Evens, M.D., as secretary-trea- 
surer of the ACR Board of 
Chancellors. Evens, a recog- 
nized authority in the socio- 
economics of medicine, was 
first named to the ACR Board 
in 1988. The 24-member 
Board is the governing body 
of the ACR, determining pol- 
icy standards for this national 
organization of more than 
28,000 radiologists. 
Mirowitz 
'& Appointed Chief 
In January of 1994, Scott 
A. Mirowitz, M.D., director of 
Jewish Hospital's magnetic 
resonance imaging section, 
will assume the responsibili- 
ties of radiologist-in-chief of 
the Institute's radiology 
department at Jewish 
Hospital. The appointment 
followed a six-month national 
search led by committee 
cochairs Ronald G. Evens, 
M.D., MIR director, and 
Wayne M. Lerner, DPH, presi- 
dent and senior executive offi- 
cer of Jewish Hospital. 
With this new alignment, 
the Institute will coordinate 
all radiologic services within 
Washington University Medical 
Center and at Barnes West in 
St. Louis County. According to 
Evens, Mirowitz will have an 
excellent opportunity to 
develop a nationally recog- 
nized academic department 
while maintaining Jewish 
Hospital's long-standing tradi- 
tion of providing excellent clin- 
ical service. Lerner believes 
the cooperative effort will fur- 
ther the roles of the Institute, 
Washington University, and 
Jewish Hospital as regional 
healthcare leaders and insti- 
tutes for scientific inquiry. 
Mirowitz has an outstand- 
ing reputation as a physician 
and a scientist. Under his 
leadership, Jewish Hospital's 
magnetic resonance imaging 
(MRI) section reported an 80 
percent growth rate over the 
past three and one-half years 
while providing quality service 
to patients and physicians. An 
alumnus of Washington Uni- 
versity School of Medicine, 
Mirowitz completed four 
years of training in diagnostic 
radiology through the MIR/ 
Jewish Hospital-affiliated resi- 
dency program and a one-year 
fellowship in magnetic reso- 
nance imaging. 
Scott A. Mirowitz, M.D. 





In recognition of the 
important role that mam- 
mography continues to play 
in women's health care, Bar- 
bara Monsees, M.D., was 
named chief of breast imag- 
ing, a new section under the 
Division of Diagnostic Radi- 
ology. As a member of the 
MIR team who, in 1986, 
brought the first mobile 
mammography van to the St. 
Louis region, Monsees is an 
effective advocate of the 
benefits of early detection of 
breast cancer through 
screening. 
Monsees, who joined 
the MIR faculty in 1980, and 
a team of researchers hold 
the patent for a radiologi- 
cally compatible filler for 
breast implants. She was 
instrumental in developing 
the new Mammography 
Screening Center at Barnes 
Hospital. The Center's loca- 
tion on the first floor of the 
hospital offers women con- 





The Board of Directors 
of the Radiological Society 
of North America (RSNA) 
appointed Bruce L. McClen- 
nan, M.D., professor of radi- 
ology and chief of MIR's 
abdominal imaging section, 
to serve on the 1994 Public 
Information Advisory Board. 
As a board member, McClen- 
nan, an expert in the assess- 
ment of radioiodinated 
contrast agents and in geni- 
tourinary radiological 
research, will review 
abstracts and help select 
papers and scientific 
exhibits featured at the 
annual RSNA symposium. 
Throughout the year, 
board members also serve as 
informational resources for 
the news media. Acknowl- 
edged as experts in scientific 
research, these physicians 
are often called upon by the 
American Medical Associa- 
tion (AMA) for clarification 
of data in reports issued by 
the AMA's Council on Scien- 
tific Affairs. This informa- 
tion is frequently published 
in specialty medical journals 
and quoted in news articles 
on health-related issues. 





"There are those who say 
that the golden age of radiol- 
ogy is past. Don't believe it. 
The future is brighter than 
ever before," admonished C. 
Douglas Maynard, M.D., 
invited speaker for the 
Twenty-second Annual Wen- 
dell G. Scott Memorial Lec- 
ture on October 11. 
Maynard, president-elect 
of the American Board of 
Radiology, is a nationally 
recognized leader in the 
advancement of radiologic 
education and has introduced 
many innovative approaches 
to learning, such as television 
programming, research train- 
ing for residents, and video- 
disk technology for board 
examinations. 
He outlined the national 
issues facing medical profes- 
sionals as a result of the 
Clinton administration's pro- 
posal for health-care reform: 
■ a perceived need to 
train more primary-care 
physicians, 
■ the debate on 
overspecialization, 
■ a requirement for 
demonstrated 
competence, 
■ turf issues between 
subspecialty groups, 
■ and the need for better 
defined quality. 
According to Maynard, 
who is chairman of the 
Department of Radiology at 
the Bowman Gray School of 
Medicine, these topics are 
"causing gentle ripples and 
radiology is caught between 
the issues." 
Accreditation is the 
subject of five congressional 
bills plus proposals by the 
Physician Payment Review 
Commission; the Association 
of American Medical Col- 
leges; the Council on Gradu- 
ate Medical Education, the 
parent organization for 
accreditation; and President 
Clinton. Common to all pro- 
posals is the recommenda- 
tion to shift the balance from 
specialties to primary care, 
limit the number of postgrad- 
uate positions, establish 
national allocation, and fund 
only approved programs. 
C. Douglas Maynard, M.D. 
(left); Mrs. Wendell Scotl- 
and Ronald G. Evens, M.D. 
Nationwide, there are 
204 accredited diagnostic 
radiology programs with 
4,164 positions, and the Resi- 
dency Review Commission is 
recognizing an increase in 
diagnostic radiology slots at 
the rate of 50 to 60 every six 
months. But Maynard pre- 
dicts that as the U.S. health- 
care system is remodeled 
over the next five years, radi- 
ology faces the potential loss 
of a large number of funded 
slots. 
Evidence of compe- 
tence and continuing compe- 
tence also is under review as 
there is a need in all special- 
ties for a formal recertifica- 
tion program. The American 
College of Radiology's reor- 
ganized Task Force on Docu- 
menting Continuing 
Competence, chaired by 
MIR's Bruce L. McClennan, 
M.D., is investigating meth- 
ods for documenting ability 
and skill of radiologists, radi- 





As one of four recipi- 
ents of the 1993 MeMn M. 
Figley Fellowship in Radiol- 
ogy Journalism, Richard M. 
Slone, M.D., recently learned 
from the masters the funda- 
mentals of medical journal- 
ism. Sponsored by the 
American Roentgen Ray 
Society (ARRS), the fellow- 
ship encourages academic 
radiology careers and stimu- 
lates interest in high quality 
radiology journalism. The 
fellowship aims to improve 
the quality of radiology pub- 
lications by teaching journal- 
ism skills early in the 
academician's career and 
providing training for manu- 
script reviewers and future 
editors. After completing 
the program, the fellowship 
recipients, as core teachers, 
can share their skills and 
knowledge of medical jour- 
nalism with colleagues. 
At the California-based 
editorial offices of the Amer- 
ican Journal of Roentgenol- 
ogy (AIR), one of the 
nation's leading scientific 
publications, Slone received 
hands-on-experience in man- 
uscript preparation and edit- 
ing, the ethics of scientific 
jounalism, and the peer 
review process. During the 
month-long fellowship, 
Slone, a clinical instructor 
and fellow in chest radiol- 
ogy, also travelled to the 
ARRS publication office in 
Virginia and to Waverly 
Press in Maryland to observe 
the mechanics of formatting 
and printing the journal. 
He is now applying tech- 
niques learned from the fel- 
lowship program to research 
projects, including an analy- 
sis of coauthorship in radiol- 
ogy literature and the peer 
review process. 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
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The Radiological Society 
of North America (RSNA) 
once again selected the 
MIR Electronic Radiology 
Laboratory (ERL) to develop 
software for a major demon- 
stration of digital information 
management at the Society's 
79th Annual Meeting, Novem- 
ber 28 through December 3. 
The Digital Imaging and 
Communication (DICOM) 
Standard, completed by the 
American College of Radiol- 
ogy (ACR) and the National 
Electrical Manufacturers 
Association (NEMA), defines 
universal storage and 
exchange of electronic images 
among the different types of 
imaging equipment. A suc- 
cessful demonstration of the 
DICOM Standard, involving 20 
major manufacturers, was 
first featured at the 1992 
RSNA Meeting, where MIR- 
developed software supplied 
the necessary bridge for 
transferring image data 
between central test nodes 
and each of the manufactur- 
ers' demonstration nodes. 
Under contract with 
RSNA, the team of Stephen M. 
Moore, M.S.; David E. 
Beecher, M.S.; Sheldon Hoff- 
man, M.S.; G. James Blaine III, 
.Sc, director of the ERL; and 
R. Gilbert Jost, M.D., director 
if the Division of Diagnostic 
diology, developed soft- 
are to support a much 
roader demonstration at 
RSNA '93 of image communi- 
cation among various manu- 






Kanematsu Medical Sys- 
tems awarded Principal 
Investigator Robert E. Drzy- 
mala, Ph.D., a one-year con- 
tract for $93,500 to develop a 
special interactive software 
package for simulating and 
planning radiotherapy treat- 
ment of the brain and for 
directing brain biopsies. The 
user-friendly system will be 
available commercially by 
late 1994 and can be used 
with digital angiography, 
computed tomography (CT), 
magnetic resonance (MR), 
and positron emission 
tomography (PET). 
During the scanning 
procedures, the patient's 
head will be immobilized by 
a stereotactic frame. The 
frame will show up as dots 
on the scans, indicating a 
definitive coordinate system. 
For 3-D treatment planning, 
the coordinate system will 
be used to target the radia- 
tion beam within one mil- 
limeter of the tumor. In 
neurosurgery, the system 
can provide better visualiza- 
tion for planning brain tissue 
biopsies; treating vascular 
abnormalities, such as arter- 
ial venous malformations 
(AVMs); and implanting 
devices that assist in chemi- 
cally or physiologically 
manipulating brain tissue. 
Coinvestigators for the 
project are Joseph R. Simp- 
son, M.D., associate profes- 
sor of radiology, and Keith 
M. Rich, M.D., associate pro- 
fessor of neurological 
surgery. 
On September 29, friends and colleagues gathered in Scarpellino Auditorium ior the 
unveiling oi the official portrait of Carlos A. Perez, M.D., director of the Radiation 
Oncology Center. Perez's internationally acclaimed expertise in the field of radiation 
oncology earned him the prestigious Gold Medal Award, presented in 1992 by the 
American Society for Therapeutic Radiology and Oncology. On hand for the portrait 
presentation were (left to right) William H. Danforth, M.D., chancellor of Washington 
University; Ronald G. Evens, M.D., director of the Institute; Perez; and Todd H. 
Wasserman, M.D., clinical chief of radiation oncology at Jewish Hospital, who spear- 
headed the commissioning of the portrait. 
Moros Receives 
Grant 
As principal investigator, 
Eduardo G. Moros, Ph.D., 
assistant professor of radiol- 
ogy and chief of hyperthermia 
physics service, received a 
three-year Biomedical Engi- 
neering Research Grant from 
The Whitaker Foundation to 
develop a system that will 
more effectively treat small 
and large superficial tumors. 
Clinical studies have 
shown that hyperthermia 
(raising the temperature of 
tumor tissue to 42-45°C for an 
extended length of time) is an 
effective adjunct to radiation 
therapy, and the simultaneous 
delivery of these therapies 
provides a more beneficial 
method of treatment. Because 
of disparity between the thera- 
pies and the delivery systems, 
including length of treatment 
and equipment design, patients 
currently receive hyperthermia 
before or after radiation. 
By integrating ultrasound 
technology with a scanning 
reflector, the MIR researchers 
propose to develop a new 
hyperthermia system, specifi- 
cally designed for simultane- 
ous use with external beam 
radiation machines. 
Coinvestigators for the 
$178,640 grant, "An Ultra- 
sound Array System for 
Simultaneous Hyperthermia 
and External Beam Radiation 
of Superficial Neoplasms," 
include William L. Straube, 
M.S., instructor in radiology; 
Robert J. Myerson, Ph.D., 
M.D., associate professor of 
radiology; Eric E. Klein, M.S., 
instructor in radiology; Daniel 
A. Low, Ph.D., instructor in 
radiology; and Bahman 
Emami, M.D., professor of 
radiology and associate direc- 
tor for research - Radiation 
Oncology Center. 
FOCAL SPOT, FALL/WINTER, 1993 
MIR researchers are using 
digital imaging to find a 
treatment that reduces the 
risk of periodontal bone loss 
in postmenopausal women. 
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Digital imaging technology analyzes periodontal bone loss 
Researchers have known for some time that postcranial bone 
loss in women is one of the physiological changes that can 
accompany menopause. But little is known about the connec- 
tion between periodontal bone loss and osteoporosis, or why some 
women lose bone more rapidly than others. Variations in periodontal 
bone loss patterns among patients first piqued the curiosity of Dr. 
Charles F. Hildebolt when he was practicing dentistry. During his nine 
years of private practice, Hildebolt saw certain patients who continued 
to lose their periodontal bone in spite of dental treatments and good 
oral hygiene. He also observed patients who continually had their den- 
tures relined or remade because of the resorption of the alveolar 
processes (bony ridges in the upper and lower jaws in which the teeth 
are anchored). In some cases those patients underwent surgical ridge 
augmentation. Hildebolt wanted to find a method of identifying and 
treating those patients at risk. Now as a researcher at Mallinckrodt 
Institute of Radiology (MIR), he has received National Institute of Den- 
tal Research funding for a four-year study on the interrelationships 
between alveolar bone loss and postmenopausal osteoporosis. 
• by Bridget McDonald 
W>man's. 
■HEAOH 
I MM ■ n dental school we were 1 taught that alveolar bone 1 loss could be caused by ill- 
fitting dentures, even though it 
appeared to be a bigger problem 
for women than men. It has also 
been suggested that both men and 
women lose the same amount of 
bone with age, but bone loss in 
women is easier to detect because 
they have less bone mass initially," 
says Hildebolt, an MIR associate 
professor of radiology who carries 
both a dentistry degree and a Ph.D. 
in physical anthropology. 
Clinicians and scientists gener- 
ally agree that the periodontal alve- 
olar bone resorbs with advancing 
age. However, it is not known how 
the estrogen therapy some post- 
menopausal women receive affects 
periodontal bone loss, or if the sys- 
temic mechanisms responsible for 
osteoporosis (bone deterioration in 
the postcranial skeleton) cause a 
simultaneous loss of periodontal 
bone. Hildebolt believes the 
causes of periodontal disease, a 
common precipitator of tooth loss 
and, consequently, also a contribu- 
tor to ill-fitting dentures in older 
women, have not been firmly estab- 
lished, though bacteria in dental 
plaque has typically been named 
the culprit. 
B: ££ W%y studying one hundred kpostmenopausal women, "we are seeking to identify 
a group at high risk for periodontal 
bone loss, show how they can be 
identified early and inexpensively, 
and find a treatment that will 
reduce the risk for this group," 
explains Hildebolt. 
The combined disciplines of dentistry and anthropol- 
ogy provide Charles Hildebolt, D.D.S., Ph.D., with a 
unique multifaceted approach to research. 
As principal investigator for 
the project, Hildebolt hypothesizes 
that the beneficial effects of estro- 
gen therapy for osteoporosis may 
also be applied to periodontal bone 
loss. The study will quantify bone 
loss of the postcranial skeleton and 
periodontal bone, while comparing 
the rate of bone loss between 
women receiving estrogen and 
placebo therapies. 
By applying NASA's 
Landsat technology, 
researchers will 
analyze digitally - 
enhanced 
radiographic images 
of the periodontal 
bones. 
MALLINCKRODT INSTITUTE OF RADIOLOG Y 
".. the health of the 
peridontal bone may 
be shown to be a 
sensitive and specific 
marker of bone mass 
changes." 
In order to study periodontal 
disease, Hildebolt had to come up 
with a way to quantify the rate of 
bone loss. That's where coinvestiga- 
tor Michael Vannier, M.D., professor 
of radiology and director of the 
Institute's Division of Radiology 
Research, has provided a significant 
contribution. A former National 
Aeronautics and Space Administra- 
tion (NASA) engineer, Vannier 
brings to radiology, through com- 
puter and programming support, the 
application of digital imaging used 
in space exploration. 
Left: Hildebolt and research team 
members Brent Rice, senior undergraduate 
student, and Naoko Yokoyama, data 
assistant. 
By applying the digital imaging 
process used by NASA's Land- 
sat technology to study the 
topographical surfaces of other 
planets, researchers at MIR will 
analyze digitally-enhanced radi- 
ographic images of the periodontal 
bone of women participating in the 
study. The scanner-based imaging 
system provides an enhanced view 
of vertical bitewing radiographs, 
similar to conventional dental X 
rays. These films, which are held 
in place in the patient's mouth by 
custom-made positioning devices, 
go through a special exposure, pro- 
cessing, and digitization procedure. 
The end result is a more focused 
contrast and edge enhancement of 
teeth and bone surfaces than is 
found in routine dental radi- 
ographs. After the images are 
enhanced, precise geometric mea- 
surements of the periodontal bone 
can be made 
The digitized image improves 
visualization of the cementoenamel 
junction (where the tooth enamel 
ends, often below the gumline) and 
the alveolar crest (the crest of the 
ridge in which the teeth are imbed- 
ded). Between these two points 
researchers will make six measure- 
ments (three on each side of the 
tooth - mesial, distal and mid- 
tooth), to be automatically stored 
in the computer data system and 
compared to other sets of measure- 
ments taken of the same teeth each 
year over a three-year period. In 
preliminary studies, the measuring 
technique using the digitally- 
enhanced images proved to be of 
submillimeter reproducibility, with 
less than .25 millimeter diversion. 




■his kind of measurement 
technique is very time 
ntensive," admits Hilde- 
bolt. "But it has a considerable 
advantage over traditional method- 
ologies for measuring periodontal 
bone loss." 
The accuracy in using this 
quantitative method is further aug- 
mented by taking measurements of 
both the facial (outer) and lingual 
(inner) crests of the alveolar ridge, 
eliminating any chance of under- 
measurement of bone loss by look- 
ing at only one surface. 
In addition to the linear mea- 
surements to be analyzed, his- 
tograms from each radiograph will 
give researchers the opportunity to 
compare bone densities in the alve- 
olar ridges. Using the specially 
designed computer software to 
select a region of interest (ROI) in 
a participant's radiographic image, 
a baseline of the plot of pixel fre- 
quencies or grey scales will be 
established for comparison of the 
three yearly radiographs. Compar- 
ing these histograms will allow 
researchers to detect the slightest 
change in bone density values. 
Additional data will be pro- 
vided through the use of INTER- 
PROBE'", a pressure-sensitive 
electronic periodontal probe. 
Using this state-of-the-art comput- 
erized probe, a gingival-probing- 
depth measurement will be made at 
six locations per tooth. The dis- 
tance from the margin of the gums 
(gingiva) to the depth of the probe 
penetration will be entered directly 
into the computer memory, with no 
manual entry required. The dis- 
tance from the cementoenamel 
junction to the depth of probe pen- 
etration also will be automatically 
entered. 
The beneficial 
effects of estrogen 
therapy for 
osteoporosis may 
also be applied to 
periodontal bone loss. 
This electronic probe manufactured by Bausch & Lomb 
Oral Care Division provides a computerized method 
for documenting periodontal disease. 
10 MALLINCKRODT INSTITUTE OF RADIOLOGY 
MM ■ f our hypothesis is correct, 
\ that alveolar bone densities 
I are reduced by systemic 
processes in a specific group of 
women, it may be that alveolar 
bone loss caused by periodontal 
disease is exacerbated in these 
women," Hildebolt suggests. "Even 
though a periodontal pocket does 
not necessarily indicate current 
disease activity, it is considered to 
be a characteristic of past peri- 
odontal disease. By comparing 
soft-tissue probing measurements 
with measurements of the alveolar 
bone, we may be able to establish if 
a specific group of postmenopausal 
women are at high risk of develop- 
ing periodontal disease." 
To investigate how changes in 
periodontal bone mass relate to 
bone mass changes in other skele- 
tal sites, changes in the height and 
density of the periodontal bone will 
be compared to changes in bone 
mineral content in the spine, fore- 
arm, and hip. A correlation matrix 
to assess these relationships will be 
computed for each yearly interval 
and for the overall data collected. 
Patients for the research pro- 
ject will be recruited at the Wash- 
ington University Medical Center 
and at the University of Cincinnati 
Medical Center. Criteria for inclu- 
sion in the study require that the 
women have at least 10 measurable 
teeth and have ceased menstrua- 
tion for at least 24 months. They 
must also be in good health and 
taking no drug treatments (other 
than calcium) known to affect bone 
metabolism. 
The illustration depicts the progression of 
alveolar bone loss, (left to right) ranging from 
normal periodontal support to moderate bone 
loss to severe resorption. 
// B I ecause of its unique associ- ation with the oral environ- 'ment, the health of the 
periodontal bone may be shown to 
be a sensitive and specific marker 
of bone mass changes within an 
individual," maintains Hildebolt. 
"Understanding the relationship 
between the bone mineral content 
of the postcranial skeleton and the 
periodontal bone in post- 
menopausal women will expand 
our knowledge of the menopausal 
influence on bone mass and may 
also provide an explanation for the 
nonperiodontal-disease-related 
alveolar bone loss in older 
females." □ 
Bridget McDonald is a free-lance writer, 
residing in the St. Louis-area. 
Plain film X rays show healthy alveolar bone (left) 
and bone loss (right). 
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In response to a call from the Society of Nuclear 
Medicine (SNM) for proposals on the use of 
unsealed sources for radiotherapy, MIR 
scientist Carolyn Anderson and a team of 
researchers received an SNM fellowship to 
compare copper-64 with copper-67. 
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PET RESEARCH SHEDS NEW LIGHT ON PROSTATE CANCER 
EWEL 
IN      THE      MAKING 
I- t is said that every man, if he reaches a ripe old age, will have 
.some stage of prostate cancer growing within him when he dies. 
That's because prostate cancer, which often causes no symptoms, can grow 
very slowly, confined to this gland for many years. If this cancer develops in a 
man in late life, death usually occurs from other causes, not the cancer. 
But every year, growing numbers of men in their forties or fifties are 
being diagnosed with the disease. Unfortunately, when prostate cancer devel- 
ops at this stage of life, it may turn lethal well before a man reaches old age. 
The cancer metastasizes to regions outside the prostate capsule before a mid- 
dle-aged man is even aware he has it. 
Within the last 10 years, diagnosing prostate cancer has become eas- 
ier. Yet every year, nearly 40,000 men die from this disease; fatalities from 
prostate cancer are second only to lung cancer. One reason stems from the fact 
that conventional checks on the prostate's status — the digital rectal exam and a 
blood test known as the PSA (prostate-specific antigen) — are far from definitive. 
If one of these tests suggests that something might be amiss, an 
ultrasound examination may be performed. Then, information from all these 
sources, considered as a whole, suggests whether a tumor is present. But many 
men shy away from having a digital rectal exam. What's more, the PSA test is 
not widely used. To add to the difficulty, results from a PSA are often impre- 
cise; erroneous conclusions are drawn from about 30 percent of PSA tests. 
Thus, the lethal statistics describing the fate of those who have 
prostate cancer are likely to persist for the foreseeable future. But at Mallinck- 
rodt Institute of Radiology, there's a jewel in the making that may turn 
advanced prostate cancer into a less deadly disease. 
by Suzanne Hagan 
MAKING 
This "jewel" is a tiny, metal- 
bearing protein. Once its 
gleam strikes the eye of a 
positron emission tomography 
(PET) scanner, which assesses bio- 
chemical processes and produces 
images of function rather than 
form, the protein should illuminate 
in unimaginable detail certain 
tumorous cells originating in the 
prostate. These cells that have 
spread to other regions of the body 
carry receptors for a hormone 
called somatostatin. 
Using her background as an 
inorganic chemist and a radio- 
chemist, Carolyn Anderson, Ph.D., 
and a team of scientists have syn- 
thesized what they hope is an 
exquisite sensor that signals, via a 
three-dimensional PET scanner, 
prostate cancer cells studded with 
somatostatin receptors. Once 
Anderson, an assistant professor in 
the Institute's Division of Radiation 
Sciences, and the other researchers 
find whether prostate cancer cells 
display receptors for somatostatin, 
they hope that oncologists will be 
able to exploit this vulnerability in 
diagnosing or treating prostate can- 
cers with somatostatin-like com- 
pounds. 
Somatostatin was once thought 
to be manufactured only in the 
brain, where it regulates the pro- 
duction of growth hormone. Now, 
it is known that many different 
types of cells throughout the body 
manufacture this tiny protein. 
What's more, many types of tumors 
can be treated with somatostatin — 
a field that's just beginning to be 
explored. 
Since somatostatin's existence 
is cut short by the body's enzymes, 
the natural form of this protein 
cannot be used therapeutically. 
Sandoz Pharmaceuticals Corpora- 
tion has manufactured a version of 
somatostatin, called octreotide 
(Sandostatin R ), that resists biolog- 
ical degradation. Currently, the 
Michael Welch, Ph.D., was one of the first researchers 
to apply modern organic chemistry to the preparation 
of radiopharmaceuticals used in medical imaging. 
Tumorous cells in the 
prostate that have 
spread to other 
regions of the body 
carry receptors for a 
hormone called 
somatostatin. 
FDA has licensed Sandostatin only 
for the treatment of symptoms of 
tumors arising in neuroendocrine 
tissue or pancreatic islets, says Joel 
Picus, M.D., a medical oncologist at 
Barnard Cancer Hospital. For 
prostate cancers that fail to 
respond to conventional treat- 
ments, Picus hopes to investigate 
whether Sandostatin is effective in 
pinpointing somatostatin receptors. 
If these receptors are present, 
what's the best way to spot them? 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
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T! £ £ /"T~1he real technical problem," says Michael Welch, Ph.D., director of the Division of 
Radiation Sciences, "has to do with 
the small number of receptors and 
the small quantities of octreotide 
they'll bind." 
Imaging modalities like com- 
puted tomography (CT) and mag- 
netic resonance imaging (MRI), 
which work well when visualizing 
milligram quantities of radiotrac- 
ers, cannot detect substances like 
"It's now thought that 
oncology research is 
the future of PET:' 
Barry Edwards, M.S. 
Tammy Pajeau, M.S. 
labeled octreotide, which are pre- 
sent in only one-millionth that con- 
centration. Although the PET 
scanner is able to detect such small 
quantities, costs and chemistry 
have gotten in the way of starting 
this new line of research. 
"Sandostatin is very expen- 
sive," points out Anderson. "It costs 
about seven hundred dollars for ten 
milligrams. What we're hoping to 
do is develop a new way of synthe- 
sizing octreotide so that we and 
other researchers who need to do 
solid-phase reactions can have an 





ying at the base of 
the penis, below 
I the bladder and in 
front of the rectum, the 
prostate gland depends 
upon the male hormone 
testosterone to produce 
a fluid that is part of 
semen. The prostate 
surrounds the upper 
portion of the urethra, the tube 
that empties urine from the 
bladder and carries semen 
through the penis. 
The cause of prostate can- 
cer is unknown, although some 
studies suggest that a low-fat 
diet may reduce the risk of 
developing prostate cancer. In 
its early stages, there are often 
no symptoms. When symptoms 
develop, they may include any 
of the following conditions: 
■ Blood in the urine 
■ Painful or burning 
urination 
■ Painful ejaculation 
■ Inability to urinate 
■ Difficulty in starting or 
stopping urination 
■ Frequent urination, 
especially at night 
■ Pain in lower back, pelvis, 
or upper thighs 
These symptoms do not 
always signal prostate cancer 
but should be checked by a 
physician. 
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rorking with collaborators 
Gregg Fields and Cindy 
Fields at the University of 
Minnesota, Anderson and organic 
chemist Barry Edwards are devel- 
oping a new and simpler version of 
octreotide. This synthesis is read- 
ily adaptable to preparing 
octreotide derivatives for PET 
imaging. 
The Minnesota team sends a 
form of octreotide to the Mallinck- 
rodt Institute researchers, who 
then take this unfinished "gem" 
through a series of steps. One of 
these steps involves attaching a 
positron-emitting metal, such as 
gallium-68 or copper-64, to 
octreotide. Tammy Pajeau, a 
senior research technician, then 
analyzes the radiolabeled com- 
pounds, determining their effi- 
ciency in binding to somatostatin 
receptors in various types of cells. 
If labeled octreotide binds to 
somatostatin receptors on prostate 
cancer cells, these sites will glow 
when viewed with either PET or 
single photon emission tomography 
(SPECT). Using a PET scanner 
that visualizes three dimensions, 
researchers can quantify the num- 
ber of receptors. 
T: £ £ A I ^ en years ago," says Welch, "no one used PET for oncology research. Now, 
nearly all the work being done on 
the current generation of PET scan- 
ners is oncology-related. It's now 
thought that oncology research is 
the future of PET." 
"This could be a 
home run, or we 
could strike out." 
One of the beauties of using 
gallium-68 or copper-64, points out 
Welch, is that these isotopes need 
not be generated in an accelerator. 
For example, copper-64 comes 
from the University of Missouri's 
Research Reactor. Not using accel- 
erator-generated isotopes brings 
down the overall costs. 
Another advantage to using 
copper-64, says Anderson, is its rel- 
Joel Pkus, M.D., assistant professor of medicine, 
is director of the hematology lab, Division of 
Medical Oncology. 
atively long half-life (12 hours): 
"Researchers can image with cop- 
per-sixty-four up to twenty-four 
hours as compared to three or four 
hours with gallium-sixty-eight. 
This allows for better contrast 
between the tumor and the rest of 
the body." 
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Ti £ £ t I 1 he other reason we're interested in using copper- sixty-four is that it also 
has potential as a radiotherapeutic 
agent," Anderson adds. "We're 
doing some studies now with cop- 
per-sixty-four linked to monoclonal 
antibodies to study tumor shrink- 
age, but this approach could also 
be used with octreotide." 
As promising as this research 
is, there are still many unknowns, 
advises Picus: "This could be a 
home run, or we could strike out." 
No one knows whether some, 
or any, human prostate cancers 
display somatostatin receptors, of 
which there are more than one 
kind, or what kind of affinity they 
would have for octreotide. 
"Almost undoubtedly" there will be 
subtypes of these receptors, if 
there are any at all, on cancer cells, 
says Picus. "Our hope is that 
octreotide will be active on all sub- 
types." 
Octreotide's usefulness in the 
treatment of prostatic cancer may 
be only as a staging tool, to discern 
information helpful to only 5 to 10 
percent of patients. "But even if 
only a small percentage of patients 
are helped," says Picus, "consider- 
ing that that's a group of about 
forty thousand every year, that's 
quite a lot." □ 
IMAGING ILLUMINATES NEW WAYS 
TO TREAT CANCER 
A few years ago, it was discovered that certain breast cancers 
grow more fiercely in the presence of estrogen if they have on 
their surface a receptor for the hormone. Estrogen that 
attaches to its receptor at a tumor cell surface kicks cell reproduc- 
tion into high gear. If these estrogen receptors are missing, then 
something other than estrogen must be the impetus behind the 
tumor's growth. 
Through the use of radiolabeled estrogens, researchers, aided by 
the clinical work of Farrokh Dehdashti, M.D., assistant professor of 
radiology, are able to illuminate the hormone's receptors. Once 
tumors that have estrogen receptors are differentiated from those 
that don't, an oncologist can choose the most effective course of 
therapy. Breast cancer cells bearing estrogen receptors on the sur- 
face may be crippled by administering therapeutic substances like 
tamoxifen. 
Tamoxifen mimics estrogen's structure and latches onto the 
receptor. Once there, tamoxifen prevents natural estrogens from 
attaching. However, the bound tamoxifen — unlike its chemical 
cousin estrogen — does not jump-start the cell's cycle of growth. 
Thus, the tumor's growth slows or stops. 
Using this radiolabeling scheme to pinpoint breast cancer cells 
carrying estrogen receptors has engaged Michael Welch, Ph.D., 
director of Mallinckrodt Institute's Division of Radiation Sciences, 
for many years. Furthermore, in collaboration with a group at Uni- 
versity of Illinois, led by John Katzenellenbogen, Ph.D., Welch 
reports that another application of this approach appears to be suc- 
cessful. 
Prostatic cancers in animals can be differentiated according to 
the presence or absence of androgen receptors, which recognize 
testosterone. Now, says Welch, human trials are about to begin, to 
see if human prostatic tumors can be differentiated based on the 
presence or absence of androgen receptors. If so, then an oncologist 
can decide whether use of an anti-androgen will be appropriate ther- 
apy. 
All of this work has been done using compounds labelled with 
non-metals, such as fluorine. But to pinpoint somatostatin receptors 
on breast cancer cells, a different approach was needed. New chem- 
ical syntheses and methods of protecting functional groups, as well 
as affixing metal isotopes, had to be devised. Carolyn Anderson, 
Ph.D., and a team of researchers, developed a way to illuminate 
these receptors in the PET scanner. "It wasn't simple," says Ander- 
son. "We thought we'd be working with patients a year ago. Now, 
we hope to begin clinical trials in 1994." 
Suzanne Hagan is a free-lance writer and editor, specializing in 
science and medicine. 
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P I la nsfor the Institute's 
new imaging research center 
were announced in this year's 
spring issue of Focal Spot. 
Scheduled for completion in 
mid-1994, the facility will be one 
of the best equipped centers 
worldwide where research 
will focus on the development 
and application of advanced 
imaging systems. 
The following is an update 
of building construction, equip- 
ment installation, and faculty 
and staff additions. 
On May 25, the world's first prototype 
of a Tandem Cascade Accelerator 
(TCA) was rolled off a delivery truck 
and installed in the basement of MIR's 
East Building. The TCA offers a less 
complex alternative to the conventional 
cyclotron-produced radiopharmaceuti- 
cals used in PET studies. The collabora- 
tion of MichaelJ. Welch, Ph.D., director 
of the Institute's Division of Radiation 
Sciences, and scientists at an indepen- 
dent research and development com- 
pany (Science Research Laboratory) 
transferred military-related technology 
developed under President Reagan's 
Star Wars program into a new cost- 
effective accelerator. 
Since the accelerator's installation, 
MIR researchers have been checking the 
purity of TCA-produced isotopes. The 
TCA will support the imaging center's 
extensive PET research in addition to the 
clinical and research PET scanners at the 
Washington University Medical Center. 
In July, a successful test run pumped 
water and gases through a "rabbit line" 
to a PET scanner in the medical center. 
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In August, a group of MR physicists, led by 
E. Mark Haacke, Ph.D., professor of radi- 
ology, moved into temporary offices on the 
third floor of the East Building, awaiting 
completion of the imaging center. These 
scientists have a broad range of research 
interests, including brain functional imag- 
ing, high resolution MR angiography, MR 
cardiopulmonary imaging, breast MR, fast 
imaging, general MR physics, and image 
reconstruction methods. 
"The idea of working as a team at the 
imaging center matches my own philoso- 
phy of research," says Haacke, who was 
formerly at Case Western Reserve Uni- 
versity in Cleveland. According to 
Haacke, he was drawn to the imaging 
center because of the top quality 3-D 
computer support available, the accessi- 
bility of contrast agent expertise, and the 
Institute's clinical reputation. He pre- 
dicts that in five years significant contri- 
butions will be made in brain functional 
imaging and particularly in MR cardiovas- 
cular imaging. Haacke believes these 
technologies will become extremely valu- 
able tools in clinical application and in 
clinical research. 
Other MR physicists are Debiao Li, 
Ph.D., assistant professor of radiology; 
Weili Lin, Ph.D., assistant professor of 
radiology; Dmitriy Yablonski, Ph.D., 
research associate; Shantanu Kaushikkar, 
M.S., programmer; James Goldfarb, M.S., 
research assistant; Ramesh Venkatesan, 
M.S., research assistant; and Song Lai, 
M.S., research assistant. 
In early September, members of the 
Institute's Division of Radiology 
Research moved into offices on the 
third floor of the East Building, which 
were previously occupied by Washing- 
ton University School of Medicine's Pro- 
gram of Physical Therapy. Under the 
leadership of Michael W. Vannier, M.D., 
professor of radiology, the Division 
serves as a focus and resource for mul- 
tiple studies in technology assessment, 
clinical protocols, electronic imaging, 
and radiologic procedures. The estab- 
lishment of the Division in 1990 indi- 
cated a major commitment to an 
expansion of clinical research projects 
at the Institute. 
Below, Gulab Bhatia, M.S., instruc- 
tor in radiology, checks on the housing 
construction for a 3-D body scanner 
that will improve procedures for fitting 
prostheses. 
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Looking like a monstrous steel stork 
carrying an overgrown bundle, a 
construction crane hoisted the 22,000- 
pound Siemens 1.5 Active Shielded 
Magnetom almost 60 feet into the air 
before depositing it onto a specially 
built ramp that led into the MIR's East 
Building. A portion of the East Build- 
ing's wall on the first-floor level had 
been removed to accommodate the 
magnet's bulk, and workers guided the 
magnet through this opening and down 
the hall into the MR research area. The 
Institute received the magnet in mid- 
October as part of a new MR scanning 
system (Siemen's first and only one 
produced to date) that offers higher 
internal processing speeds, faster data 
acquisition, and larger memory banks 
than any other MR scanner now in use. 
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Offices and research areas are being 
constructed on the second floor of 
the East Building to house the neuro- 
logical PET research faculty and staff, 
headed by Marcus E. Raichle, M.D., 
professor of radiology and neurology. 
Scheduled to move into their new facil- 
ities in early 1994, these PET scientists 
have focused their work on normal 
brain functions as well as major neuro- 
logic and psychiatric disorders. Of 
special interest is the functional map- 
ping of the brain, especially the areas 
involved in sensory and language infor- 
mation processing. 
0   A   I   !   U    P    D 
The future home of Mallinckrodt 
Institute's imaging research center, 
at the corner of Scott and Taylor 
avenues, was once covered with 
asphalt and carried the sole distinction 
of "offering the closest parking to the 
East Building." Within the past four or 
five months, the site was excavated, 
foundations were 
laid, and steel sup- 
port girders were 
set in place — all 
in preparation for 
the construction of 
a freestanding 
structure that will 
include four floors 
(counting the base- 
ment), cover 50,000 
square feet, and 
house more than 
100 faculty and staff 
members. 





James W. Debnam, M.D., 
assistant professor of clini- 




research assistant in radiol- 
ogy, Division of Diagnostic 
Radiology 
Peter E. Shile, M.D., assis- 
tant professor of radiology, 
Division of Diagnostic 
Radiology 
Robert A. Whitman, M.S., 
research associate in radiol- 
ogy, Division of Diagnostic 
Radiology 
Nathan C. Nelson, M.S., 
instructor in radiology, Divi- 
sion of Nuclear Medicine 
Rupak Kumar Das, Ph.D., 
research associate, Division 
of Radiation Oncology 
Weihua He, M.S., research 
assistant, Division of Radia- 
tion Oncology 
Assen S. Kirov, Ph.D., 
research associate, Division 
of Radiation Oncology 
David J. Scherer, M.S., 
instructor in radiology, Divi- 
sion of Radiology Research 
Lei Zheng, Ph.D., research 
associate, Division of Radia- 
tion Sciences 
PROMOTIONS 
Timothy J. McCarthy, 
Ph.D., was promoted to 
research instructor in radiol- 
ogy, Division of Radiation 
Sciences. 
OFF STAFF 
Clinton M. Anderson, 
M.D., instructor in radiology, 
completed a four-year resi- 
dency and a one-year fellow- 
ship in magnetic resonance 
imaging, and has entered pri- 
vate practice with Colorado 
Imaging Association in 
Denver. 
Carlos F. Aquino-Aponte, 
M.D., instructor in radiology, 
completed a one-year fellow- 
ship in magnetic resonance 
imaging and has accepted a 
position with the Veterans 
Administration Hospital in 
San Juan, Puerto Rico. 
Gregg A. Baran, M.D., 
instructor in radiology, 
completed a two-year fellow- 
ship in neuroradiology and 
has entered private practice 
in St. Petersburg, Florida. 
Meredith W. Bell, M.D., 
instructor in radiology, com- 
pleted a one-year fellowship 
in abdominal radiology and 
has accepted a position in 
the Department of Radiol- 
ogy, Duke University Med- 
ical Center. 
Richard L. Butler, M.D., 
completed one year of train- 
ing in nuclear medicine and 
has entered private practice 
in Godfrey, Illinois. 
Leeanna Dick, M.D., 
instructor in radiology, 
completed a one-year fellow- 
ship in vascular and inter- 
ventional radiology and has 
entered private practice 
with Durham Radiology 
Associates, Durham, North 
Carolina. 
Gerard M. Eagar, M.D., 
completed one year of train- 
ing in diagnostic radiology 
and has accepted a position 
in the Department of Radiol- 
ogy, Taranaki Base Hospital, 
New Plymouth, New 
Zealand. 
Humberto M. Fagundes, 
M.D., instructor in radiology 
and chief resident, Division 
of Radiation Oncology, 1992- 
1993, completed a three-year 
residency and a one-year fel- 
lowship in radiation oncol- 
ogy. He has accepted the 
position of head of the 
GI/GU radiation section at 
Loyola University. 
Jeffrey E. Fischbein, M.D., 
instructor in radiology, com- 
pleted a one-year fellowship 
in neuroradiology and has 
accepted a position with 
Good Samaritan Hospital, 
West Palm Beach, Florida. 
Robin Frank-Gerszberg, 
M.D., instructor in radiology, 
completed a one-year fellow- 
ship in pediatric radiology 
and has entered private prac- 
tice with the Radiologic 
Group of North Jersey, 
Wayne, New Jersey. 
M. Gena Frederick, M.D., 
completed four years of 
training in diagnostic radiol- 
ogy and has received an 
abdominal fellowship at 
Bowman Gray Medical 
Center, Winston-Salem. 
Neal A. Frenkel, M.D., 
completed a four-year resi- 
dency in diagnostic radiol- 
ogy and has received a 
cross-sectional imaging/body 
imaging fellowship at Jack- 
son Memorial Hospital, 
Miami. 
Anastasios Georgiou, 
M.D., instructor in radiology, 
completed a three-year resi- 
dency and a one-year fellow- 
ship in radiation oncology, 
and has entered private prac- 
tice with Jackson/Madison 
General Hospital, Jackson, 
Tennessee. 
Patrick O. Gordon, M.D., 
instructor in radiology, com- 
pleted a one-year fellowship 
in vascular and interven- 
tional radiology and has 
entered private practice in 
Jacksonville, Florida. 
Rosalie J. Hagge, M.D., 
completed one year of train- 
ing in nuclear medicine and 
has received an appointment 
as resident physician in the 
Diagnostic Radiology 
Scholar's Program at Duke 
University Medical Center. 
Dale P. Harris, M.D., com- 
pleted four years of training 
in diagnostic radiology and 
has received a body imaging 
fellowship at Stanford 
University. 
Paul S. Hsieh, M.D., com- 
pleted four years of training 
in diagnostic radiology and 
has accepted a position in 
the Department of Radiol- 
ogy, Cedars-Sinai Medical 
Center, Los Angeles. 
Edith H. Kang, M.D., 
instructor in radiology and 
chief resident, Division of 
Diagnostic Radiology, 1991- 
1992, completed four years 
of training in diagnostic radi- 
ology and a one-year fellow- 
ship in magnetic resonance 
imaging. She has entered 
private practice with the 
Ramsey Clinic, St. Paul, 
Minnesota. 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
■nnH 
Karl W. King, M.D., 
instructor in radiology, com- 
pleted a three-year residency 
and a one-year fellowship in 
radiation oncology and has 
entered private practice with 
Radiology Inc., South Bend, 
Indiana. 
Mark D. Mayhle, M.D., 
instructor in radiology, com- 
pleted four years of training 
in diagnostic radiology and a 
one-year fellowship in vascu- 
lar and interventional radiol- 
ogy. He has entered private 
practice with Rock Hill Radi- 
ologists, Raytown, Missouri. 
Chun Ma, Ph.D., research 
associate, Division of Radia- 
tion Sciences 
Cynthia F. Morrison, 
M.D., instructor in radiology, 
Division of Diagnostic 
Radiology 
William A. Murphy, Jr., 
M.D., professor of radiology 
and cochief of the muscu- 
loskeletal section, has 
accepted the position of 
chairman of the Division of 
Diagnostic Imaging, M.D. 
Anderson Cancer Center, 
Houston. 
Kurt L. Openshaw, M.D., 
instructor in radiology, com- 
pleted a one-year fellowship 
in vascular and interven- 
tional radiology and has 
entered private practice with 
St. Joseph Hospital, Orange, 
California. 
Nhan P. Truong, M.D., 
instructor in radiology, com- 
pleted a one-year fellowship 
in musculoskeletal radiology 
and has accepted a position 
at St. Francis Hospital, 
Tulsa. 
John F. Walsh, M.D., com 
pleted a one-year fellowship 
in nuclear medicine and has 
returned to active duty with 
the United States Air Force, 
Wilford Hall, San Antonio. 
Jonathan White, M.D., 
completed six months of 
training in nuclear medicine 
and has entered private prac- 
tice with the Maine Medical 
Center, Portland. 
Mark S. Zobel, M.D., com- 
pleted four years of training 
in diagnostic radiology and 
has accepted a position at 




Martin M. Anbari, M.D., 
received his Bachelor of Arts 
degree in natural science, 
medical degree, and law 
degree from the University 
of Pennsylvania. 
H. Scott Beasley, M.D., 
received his Bachelor of Sci- 
ence degree in optometry 
and his medical degree from 
Indiana University. He is a 
member of Alpha Omega 
Alpha. 
John A. Butman, M.D., 
received his Bachelor of Sci- 
ence degree in applied math- 
ematics and biology from the 
California Institute of Tech- 
nology and his medical 
degree from Washington 
University. 
Dayne D. Hassell, III, 
M.D., received his Bachelor 
of Arts degree in history and 
French from Tulane Univer- 
sity and his medical degree 
from the University of 
Chicago - Pritzker. 
John J. Healey, II, M.D., 
received his Bachelor of Arts 
degree in biology from 
Emory University and his 
medical degree from the Uni- 
versity of Texas Southwest- 
ern Medical School, Dallas. 
He is a member of Alpha 
Omega Alpha. 
Donald V. Heck, M.D., 
received his Bachelor of Sci- 
ence degree in mathematics 
from Wake Forest University 
and his medical degree from 
Duke University. He is a 
member of Alpha Omega 
Alpha. 
David A. Hillier, M.D., 
received his Bachelor of Arts 
degree in biology and Bache- 
lor of Science degree in elec- 
trical engineering from 
Swarthmore College; Doctor- 
ate of Science in electrical 
engineering from Washing- 
ton University, Sever Insti- 
tute of Technology; and 
medical degree from Wash- 
ington University School of 
Medicine. He has completed 
an internship in internal 
medicine at Barnes Hospital, 
St. Louis. 
William P. James, M.D., 
received his Bachelor of Arts 
degree in biology from 
Washington University and 
his medical degree from Uni- 
versity of Missouri School of 
Medicine, Columbia. 
Debra M. Lau, M.D., 
received her Bachelor of 
Arts degree in biology from 
Barnard College at Columbia 
University and her medical 
degree from Albert Einstein 
College of Medicine, Yeshiva 
University. She is a member 
of Alpha Omega Alpha. 
Robert C. McKinstry, III, 
Ph.D., M.D., received his 
Bachelor of Science degree 
in electrical engineering 
from Boston University, mas- 
ters degree in nuclear engi- 
neering and doctorate 
degree in radiological sci- 
ences from Massachusetts 
Institute of Technology, and 
medical degree from Har- 
vard Medical School. 
Felix Song, M.D., received 
his Bachelor of Science 
degree in chemical engineer- 
ing from the University of 
Illinois and his medical 
degree from Washington 
University. 
John E. Sunderland, M.D., 
received his Bachelor of Sci- 
ence degree in medical 
dietetics from The Ohio 
State University College of 
Medicine School of Allied 
Medical Professions, masters 
degree in nutritional bio- 
chemistry from Harvard Uni- 
versity, and medical degree 
from The Ohio State Univer- 
sity College of Medicine. He 
is a member of Alpha Omega 
Alpha. 
Scott A. Werden, M.D., 
received his bachelors 
degree in biologic sciences 
and his medical degree from 
the State University of New 
York at Stony Brook. He 
completed an internship in 
internal medicine at Duke 
University Medical Center 
and a residency in internal 
medicine at Boston City 
Hospital. Werden is a mem- 
ber of Alpha Omega Alpha. 
NEW FELLOWS 
Edward E. C. Angtuaco, 
M.D., instructor in radiology, 
is a fellow in neuroradiology. 
He received his Bachelor of 
Science degree in biology 
from Ateneo de Manila Uni- 
versity, Philippines, and his 
medical degree from Univer- 
sity of the East Ramon 
Magsaysay Memorial Med- 
ical Center, Philippines. 
Angtuaco completed an 
internship and a diagnostic 
radiology residency at the 
University of Arkansas for 
Medical Sciences, Little 
Rock. He has received 
American Board of Radiol- 
ogy certification. 
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Scott M. Baker, M.D., 
instructor in radiology and 
chief resident, Division of 
Diagnostic Radiology, 1992- 
1993, is a fellow in abdomi- 
nal imaging. He completed 
four years of training in radi- 
ology at Mallinckrodt Insti- 
tute of Radiology. Baker is a 
member of Alpha Omega 
Alpha. 
Clifford D. Barker, M.D., 
instructor in radiology, is a 
fellow in magnetic reso- 
nance imaging. He received 
his Bachelor of Science 
degree in mechanical engi- 
neering from Cornell Univer- 
sity and his medical degree 
from New York Medical Col- 
lege. Barker completed an 
internship in internal medi- 
cine at Waterbury Hospital, 
Connecticut, and was chief 
resident, diagnostic radiol- 
ogy, 1991-1992, at New York 
University Medical Center. 
He is a member of Alpha 
Omega Alpha. 
Benjamin J. Bartnicke, 
M.D., instructor in radiology, 
is a fellow in abdominal 
imaging. He completed four 
years of training in radiology 
at Mallinckrodt Institute of 
Radiology. 
Harold F. Bennett, M.D., 
Ph.D., instructor in radiol- 
ogy, is a fellow in abdominal 
imaging. He received his 
Bachelor of Science degree 
in nuclear engineering from 
the University of Illinois, 
masters degree in nuclear 
engineering from the Univer- 
sity of Florida, doctorate 
degree in nuclear engineer- 
ing from the University of 
Illinois, and medical degree 
from the University of Illi- 
nois College of Medicine. 
Bennett completed an intern- 
ship at Methodist Hospital, 
Indianapolis, and a residency 
in diagnostic radiology at the 
University of California, San 
Francisco. He has received 
American Board of Radiol- 
ogy certification. 
Marc A. Borge, M.D., 
instructor in radiology, is a 
fellow in vascular and inter- 
ventional radiology. He 
received his Bachelor of Arts 
degree in biology from Car- 
leton College and his med- 
ical degree from the 
University of Chicago- 
Pritzker. Borge completed a 
residency in diagnostic radi- 
ology at the University of 
North Carolina Hospitals, 
Chapel Hill. 
Kun S. Chao, M.D., instruc- 
tor in radiology, is a fellow in 
radiation oncology. He com- 
pleted two years of resi- 
dency in radiation oncology 
at Mallinckrodt Institute of 
Radiology. 
John J. Crowley, M.D., 
instructor in radiology, is a 
fellow in pediatric radiology. 
He received his undergradu- 
ate degree from Belvedere 
College, Dublin, Ireland, and 
his medical degree from 
Trinity College, Dublin. 
Crowley completed a resi- 
dency in diagnostic radiol- 
ogy at Allegheny General 
Hospital, Pittsburgh. 
Patrick D. Datoc, M.D., 
instructor in radiology, is a 
fellow in magnetic reso- 
nance imaging. He received 
his Bachelor of Science 
degree in biology from Yale 
University and his medical 
degree from the Medical Col- 
lege of Virginia. Datoc com- 
pleted a residency in radiol- 
ogy at the University of 
North Carolina Hospitals, 
Chapel Hill. He is a member 
of Alpha Omega Alpha and 
has received American 
Board of Radiology 
certification. 
Lane A. Deyoe, M.D., 
instructor in radiology, is a 
fellow in vascular and inter- 
ventional radiology. He 
completed a one-year fellow- 
ship in abdominal imaging at 
Mallinckrodt Institute of 
Radiology. 
David S. Gierada, M.D., 
instructor in radiology, is a 
fellow in chest radiology. He 
received his Bachelor of Sci- 
ence degree in cell and mole- 
cular biology from the 
University of Michigan, Ann 
Arbor, and his medical 
degree from Wayne State 
University. Gierada com- 
pleted an internship in inter- 
nal medicine/pediatrics at 
Strong Memorial Hospital, 
Rochester, and a residency 
in diagnostic radiology at 
Milwaukee County Hospital. 
He is a member of Alpha 
Omega Alpha and has 
received American Board of 
Radiology certification. 
Carolyn A. Haerr, M.D., 
instructor in radiology, is a 
fellow in musculoskeletal 
radiology. She received her 
Bachelor of Science degree 
in Spanish from Creighton 
University and her medical 
degree from the University 
of Nebraska Medical Center. 
Haerr completed an intern- 
ship and a residency in pedi- 
atrics at the University of 
Colorado Health Sciences 
Center, Denver, and a resi- 
dency in radiology at Denver 
Presbyterian Hospital, Den- 
ver. She has received Ameri- 
can Board of Radiology 
certification. 
Gregory A. Hatfield, M.D., 1 
instructor in radiology, is a 
fellow in neuroradiology. He l 
received his B.E.E. degree in I 
signal processing and bio- 
medical engineering from 
the University of Minnesota, I 
Institute of Technology; M.S. I 
degree in engineering from 
the University of California,  I 
Los Angeles; and medical 
degree from the University 
of Minnesota Medical 
School, Minneapolis. He 
completed an internship at 
St. Mary's Hospital, San 
Francisco, and a residency inl 
diagnostic radiology at the 
University of Michigan, Ann I 
Arbor. Hatfield has received I 
American Board of Radiol- 
ogy certification. 
Maurice L. King, M.D., 
instructor in radiology, is a 
fellow in radiation oncology. I 
He completed two years of 
residency in radiation oncol-1 
ogy at Mallinckrodt Institute I 
of Radiology. 
Charles T. McConnell, 
M.D., instructor in radiology, 
is a fellow in neuroradiology. 
He received his Bachelor of 
Arts degree in chemistry and 
zoology from Miami Univer- 
sity, Oxford, and his medical 
degree from Ohio State Uni- 
versity, Columbus. He com- 
pleted an internship in 
internal medicine and a resi- 
dency in radiology at The 
Ohio State University Hospi- 
tals. McConnell has received 
American Board of Radiol- 
ogy certification. 
Timothy R. O'Leary, M.D., 
instructor in radiology, is a 
fellow in radiation oncology. 
He completed a three-year 
residency in radiation oncol- 
ogy at Mallinckrodt Institute 
of Radiology. 
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Allen B. Oser, M.D., 
instructor in radiology and 
cochief resident, Division of 
Diagnostic Radiology, 1992- 
1993, is a fellow in neurora- 
diology. He completed a 
four-year residency at 
Mallinckrodt Institute of 
Radiology. 
James V. Piephoff, III, 
M.D., instructor in radiology 
and chief resident, Division 
of Radiation Oncology, 1993- 
1994, is a fellow in radiation 
oncology. He completed a 
three-year residency at 
Mallinckrodt Institute of 
Radiology. 
Gregory R. Saboeiro, 
M.D., instructor in radiology, 
is a fellow in vascular and 
interventional radiology. He 
received his Bachelor of Sci- 
ence degree in biology from 
Washington University and 
his medical degree from St. 
Louis University School of 
Medicine. Saboeiro com- 
pleted a residency in diag- 
nostic radiology at St. Louis 
University Medical Center. 
He is a member of Alpha 
Omega Alpha and has 
received American Board of 
Radiology certification. 
I Maria E. Schmidt, M.D., 
instructor in radiology, is a 
fellow in breast imaging. 
She completed three years of 
training at Mallinckrodt 
Institute of Radiology. 
Joseph A. Schoenberger, 
IM.D., instructor in radiol- 
ogy, is a fellow in vascular 
I and interventional radiology. 
I He received his Bachelor of 
I Arts degree in chemistry and 
i his medical degree from St 
Louis University. Schoen- 
berger completed a resi- 
dency in diagnostic 
radiology at the Cleveland 
Clinic and has received 
i American Board of Radiol- 
j ogy certification. 
Kevin L. Shady, MJJ., 
instructor in radiology, is a 
fellow in magnetic reso- 
nance imaging. He com- 
pleted four years of training 
in diagnostic radiology at 
The Jewish Hospital of St. 
Louis. 
Richard M. Slone, M.D., 
instructor in radiology, is a 
fellow in chest radiology. He 
received his Bachelor of Sci- 
ence degree in physics from 
Stetson University, Deland, 
Florida, and his medical 
degree from the University 
of Florida, Gainesville. 
Slone completed a residency 
in radiology at Shands 
Hospital, University of 
Florida, and has received 





Steven M. Roth, M.D., 
received his undergraduate 
degree from the University 
of Pittsburgh School of Phar- 
macy and his medical degree 
from Temple University. He 
completed an internship in 
orthopedic surgery at the 
Hospital of University of 
Pennsylvania. Roth is a 
member of Alpha Omega 
Alpha. 
Thomas E. Vaughan, M.D., 
received his undergraduate 
and medical degrees from 
Washington University. He 
completed an internship in 
internal medicine at 
Portsmouth Naval Hospital. 
Vaughan is a member of 
Alpha Omega Alpha. 
Steven S. Winn, MJJ., 
received his undergraduate 
degree from McGill Univer- 
sity and his medical degree 
from Albany Medical College 
of Union University. He 
completed an internship in 
radiology at The Albany 
Medical Center. Winn is a 





Stephen J. Kennedy, M.D., 
received his Bachelor of Sci- 
ence degree in electrical 
engineering and his medical 
degree from Ohio State Uni- 
versity. He was cochief resi- 
dent, 1991-1992, diagnostic 
radiology, at Shands 
Hospital, University of 
Florida. 
James D. Matthews, M.D., 
received his Bachelor of Sci- 
ence degree in biology and 
music from the College of 
William and Mary and his 
medical degree from the 
Medical College of Virginia. 
He completed four years of 
training in diagnostic radiol- 
ogy at Mallinckrodt Institute. 
Matthews is a member of 
Alpha Omega Alpha. 
Thomas H. Vreeland, M.D., 
received his Bachelor of Sci- 
ence degree in biochemistry 
from Louisiana State Univer- 
sity, Bachelor of Science 
degree in pharmacy from 
Northeast Louisiana Univer- 
sity, and medical degree 
from Louisiana State Univer- 
sity Medical Center. He 
completed an internship in 
internal medicine at 
Louisiana State University 
Medical Center and a resi- 
dency in radiology at the 
Medical Center of Virginia. 
Vreeland is a member of 




Bradley A. Kramer, M.D., 
received his Bachelor of Sci- 
ence degree in chemistry 
from Marquette University, 
Milwaukee, and his medical 
degree from The Medical 
College of Wisconsin. 
Alfred Tinger, M.D., 
received his undergraduate 
degree in physics from State 
University of New York at 
Binghamton and his medical 
degree from State University 
of New York - Health Center 
at Brooklyn. He is a member 
of Alpha Omega Alpha. 
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Kyongtae Tyler Bae, M.D., 
second-year resident, spoke 
on "Automatic Detection of 
Pulmonary Nodules in CT 
Images" at the National Insti- 
tutes of Health Research 
Festival, Bethesda, Septem- 
ber 20 -24. 
James A. Brink, M.D., 
assistant professor of radiol- 
ogy, spoke on "Intravenous 
Contrast Administration for 
Spiral Computed Body 
Tomography" at the William 
Beaumont Army Medical 
Center, El Paso, Texas, Sep- 
tember 22. 
Carmen S. Dence, M.S., 
research instructor in radiol- 
ogy, presented "The Devel- 
opment of Positron Emitting 
Radiopharmaceuticals," 
Shanghai Medical University, 
China; "The Recent Develop- 
ments in Low Energy Accel- 
erators," Chinese Academy 
of Sciences, Nuclear 
Research Center, Shanghai; 
and "PET Research at Wash- 
ington University," Bering 
Normal University, China, 
October 30 - November 14. 
Bahman Emami, M.D., pro- 
fessor of radiology and asso- 
ciate director for research - 
Radiation Oncology Center, 
presented "3D Conformal 
Radiotherapy for Bron- 
chogenic Carcinoma: A 
Review of State-of-the-Art" 
at the IASLC Workshop, 
Bruge, Belgium, August 29 - 
September 2. 
Louis A. Gilula, M.D., pro- 
fessor of radiology and 
director of the muscu- 
loskeletal section, presented 
refresher courses on "Ankle 
Tenosynovitis - Tenography 
and MRI" and "Dissociative 
Patterns of the Wrist" at the 
20th Annual International 
Skeletal Society Meeting, 
Toronto, August 15 - 20. He 
organized and directed the 
International Wrist Investiga- 
tors' Workshop, September 
28, Kansas City, Missouri. 
Gilula also displayed an 
exhibit on "Tailored Wrist 
Instability Series"(coau- 
thored with Nhan Truong, 
M.D., St. Francis Hospital, 
Tulsa; Frederick Mann, 
M.D., University of Washing- 
ton Medical Center, Seattle; 
and Si-Won Kang, M.D., 
visiting physician, Taiwan) 
at the American Society for 
Surgery of the Hand, Kansas 
City, Missouri, September 
29 - October 2. 
Harvey S. Glazer, M.D., 
associate professor of radiol- 
ogy, spoke on "CT of the 
Mediastinum - Differential 
Diagnosis," "Pitfalls in Radio- 
logic Evaluation of Bron- 
chogenic Carcinoma," and 
"CT of the Bronchi" at Chest 
Imaging -1993, Harvard Med- 
ical School, Boston, October 
18-21. 
Jay P. Heiken, M.D., pro- 
fessor of radiology and codi- 
rector of computed body 
tomography, lectured on 
"Spiral CT: Overview and 
Technical Considerations," 
"Spiral CT: Applications in 
the Abdomen," "Hepatic 
Masses: Detection and Char- 
acterization with CT and 
MRI," and "CT of the Peri- 
toneal Spaces: Anatomy and 
Fluid Collections" at Sum- 
mer Imaging and Interven- 
tional Techniques XI, 
sponsored by Emory Univer- 
sity School of Medicine, 
Amelia Island, Florida, 
August 2-6. He also spoke 
on "MR of the Kidneys and 
Adrenals," "MR Evaluation of 
Gynecologic Neoplasms," and 
"MR of the Liver: Lesion 
Detection and Characteriza- 
tion" at Magnetic Resonance 
Imaging 1993: Back to the 
Future, sponsored by the Uni- 
versity of Cincinnati Depart- 
ment of Radiology, 
Cincinnati, October 13 -16. 
Benjamin C. P. Lee, M.D., 
associate professor, as visit- 
ing professor, spoke on "New 
Techniques of MR Imaging" 
at the Neurological Institute, 
Lanzhou Medical Center, 
Gansu, China, September 
13-16. 
Timothy J. McCarthy, 
Ph.D., research instructor in 
radiology, presented "Recent 
Developments in Radiophar- 
maceutical Production at 
Washington University" to 
the Faculty Pharmaceutical 
Services, Kyushu University, 
Fukuoka, Japan, October 18. 
Bruce L. McClennan, M.D., 
professor of radiology and 
chief of abdominal imaging, 
as chairman, organized 
"Health Care System Reform: 
Opportunities and Exigen- 
cies," the Summit Meeting, 
Aspen, August 6 - 8. He 
spoke on "Diagnostic Imaging 
Evaluation of Benign Prosta- 
tic Hypertrophy," "Imaging of 
Acute Renal Infections," 
"Reactions to Iodinated Con- 
trast Media," "The Retroperi- 
toneum," "Imaging of Renal 
and Adrenal Carcinoma," and 
"Laparoscopic Urologic 
Surgery: What Do Radiolo- 
gists Need to Know?" at Radi- 
ology in Biarritz, France, 
September 26 - October 1. 
Ali Soleimani-Meigooni, 
Ph.D., assistant professor in 
radiology, Division of Radia- 
tion Oncology, as invited lec- 
turer, spoke on "Quality 
Assurance and Clinical Imple- 
mentation of Pulsed Dose 
Rate Remote Afterloading 
System," Missouri Valley 
Chapter of the American 
Association of Physicists in 
Medicine Society, October 
22 - 23. 
Stephen M. Moerlein, 
Ph.D., associate professor of 
radiology and biochemistry, 
as invited lecturer, presented 
"Development of Radioli- 
gands for PET Study of Brain 
Receptors" at the Technical 
University of Munich, Ger- 
many, July 29. As invited lec- 
turer, he spoke on "Pharmacy 
Practice and PET" at the 
206th National Meeting of the 
American Chemical Society, 
Chicago, August 22 - 27. 
Moerlein displayed a poster 
exhibit, "Comparison of [F- 
18] Benperidol and N-Methyl- 
[F-18] Benperidol as D-2 
Receptor-Binding PET Lig- 
ands" (coauthored with Joel 
S. Perlmutter, M.D., associ-1 
ate professor of neurology 
and radiology; David 
Parkinson, Ph.D., WUMS 
assistant professor of cell 
biology and physiology; and 
Michael J. Welch, Ph.D., 
professor of radiology and 
director of the Division of 
Radiation Sciences) at the 
23rd Annual Meeting of the 
Society for Neuroscience, 
Washington, D.C., November 
7-12. 
Eduardo G. Moros, Ph.D., 
assistant professor of radiol- 
ogy and chief of the hyper- 
thermia physics service, as 
invited lecturer, presented 
"The Simultaneous Delivery 
of External Photon/Electron 
Beam Radiation and Superfi- 
cial Microwave/Ultrasound 
Ilyperthermia" to the Radia- 
tion Oncology Department, 
University of California, San 
Francisco, September 14. 
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\lt James A. Purdy, Ph.D., 
professor of radiology and 
associate director of the 
Radiation Oncology Center, 
presented "Volume and Dose 
Specifications: A Prerequi- 
site for QA" at the 1993 
American College of Radiol- 
ogy Symposium, "Quality 
Assurance of Radiation Ther- 
apy Treatment Planning Sys- 
tems," Washington D.C., 
August 13. 
Joseph L. Roti Roti, Ph.D., 
professor of radiology, asso- 
ciate director of the Radia- 
ton Oncology Center, and 
chief of the cancer biology 
section, spoke on "DNA 
Supercoiling, The Nuclear 
Matrix and the Response of 
Mammalian Cells to Ionizing 
Radiation" at the Annual 
Meeting of the Japan Radia- 
tion Research Society, 
Hiroshima, October 28. He 
presented "Heat Modified 
Nuclear Proteins Associated 
with the Nuclear Matrix" at 
the Aichi Cancer Center 
Research Institute, Nagoya, 
Japan, November 1. Roti 
Roti lectured on "Role of the 
Nuclear Matrix in DNA Orga- 
nization and Radiosensitiv- 
ity" to the Department of 
Radiation Oncology Faculty 
of Medicine, University of 
Tokyo, November 2. He also 
spoke on "Involvement of 
Topoisomerase II in Radia- 
tion Induced G2 Delay" at the 
Department of Radiation 
Research, Tokyo Metropoli- 
tan Institute of Medical Sci- 
ence, Tokyo, November 4. 
Henry D. Royal, M.D., pro- 
fessor of radiology and asso- 
ciate director of the Division 
of Nuclear Medicine, pre- 
sented "Chernobyl: Percep- 
tions and Realities," "Effects 
of Low Level Radiation: Sci- 
entific and Public Views," 
and "Risk Communicaton" at 
the Bethesda Naval Medical 
Center, Maryland, October 
18. As visiting professor, he 
spoke on "The International 
Chernobyl Project" at the 
Joint Program in Nuclear 
Medicine, Harvard Medical 
School, Boston, October 21. 
Royal presented "Health 
Care Reform: Scientific 
Challenges" and "Chernobyl: 
Perceptions and Realities" at 
the 26th Annual Meeting of 
the New England Chapter, 
Society of Nuclear Medicine, 
Newport, Rhode Island, 
October 22 - 24. 
Stuart S. Sagel, M.D., pro- 
fessor of radiology, chief of 
chest radiology, and cochief 
of computed body tomogra- 
phy, spoke on "CT of the 
Pericardium," "High Resolu- 
tion CT of the Pulmonary 
Parenchyma," and "CT of the 
Pleura" at the Third Summer 
Practicum of the Society of 
Computed Body Tomogra- 
phy and Magnetic Resonance 
Meeting, Keystone, Col- 
orado, August 15 -19. As vis- 
iting professor, he presented 
"Spiral CT in the Thorax" 
and "CT of Asbestos-related 
Thoracic Disease" at the Uni- 
versity of Chicago, Septem- 
ber 14. Also as visiting 
professor, Sagel presented 
"CT of Vascular Mediastinal 
Lesions;" "CT of the Thorax: 
Anatomy, Pitfalls;" and 
"Chest Radiology: Low Tech 
to High Tech" at Michigan 
State University, East 
Lansing, November 9. 
Barry A. Siegel, M.D., pro- 
fessor of radiology and medi- 
cine, and director of the 
Division of Nuclear Medi- 
cine, as guest lecturer, spoke 
on "Radiopharmaceuticals 
and the FDA" at the Univer- 
sity of Texas, M.D. Anderson 
Cancer Center, Houston, 
September 28. He also 
spoke on "The Scintigraphic 
Evaluation of Pulmonary 
Embolism" at the Bethesda 
Nuclear Medicine Course, 
National Naval Medical Cen- 
ter, Bethesda, October 27. 
Marilyn J. Siegel, M.D., 
professor of radiology, pre- 
sented "CT of Congenital 
Lung Malformations" and 
"CT of the Pediatric Pan- 
creas" at the Third Summer 
Practicum of the Society of 
Computed Body Tomogra- 
phy and Magnetic Resonance 
Meeting, Keystone, Col- 
orado, August 15 -19. She 
lectured on "CT/MRI of the 
Pediatric Mediastinum" at 
the Houston Radiological 
Society, Houston, September 
27. As visiting professor, 
Siegel presented "CT/MR of 
the Pediatric Mediastinum" 
at the University of Texas 
Health Science Center, 
Houston, and "Pediatric 
Retroperitoneum" at the 
Baylor University College of 
Medicine, Houston, Septem- 
ber 28. She also presented 
"CT of the Pediatric Medi- 
astinum," "Imaging of the 
Pediatric Kidney," and 
"Ultrasonography of the 
Acute Abdomen" at the 
Michigan Fall Radiology 
Conference, Birmingham, 
October 16. Siegel spoke on 
"Gynecologic and Testicular 
Sonography in Children" at 
the American Academy of 
Pediatrics 1993 Annual Meet- 
ing, Washington, D.C., Octo- 
ber 29. As a visiting 
professor, she lectured on 
"Chest Applications of MRI 
in Children," "MRI of 
Abdominal and Pelvic 
Masses in Children," and 
"Ultrasonography of Acute 
Abdominal Pain in Children" 
at the Technion-Israel Insti- 
tute of Technology, Haifa, 
November 9. 
Richard M. Slone, M.D., 
clinical instructor in radiol- 
ogy, presented "Chest Radi- 
ology" at the University of 
California, San Diego, 
August 16. 
Michael W. Vannier, M.D., 
professor of radiology and 
director of the Division of 
Radiology Research, pre- 
sented "Electronic Atlas of 
the Human Body" at the 
1993 Society of Exploration 
Geophysicists Summer 
Research Workshop, Rancho 
Mirage, California, August 4. 
He spoke on "3D Biomedical 
Imaging" at Radiology 
Grand Rounds, Emory 
University Hospital, Atlanta, 
September 29. 
Michael J. Welch, Ph.D., 
professor of radiology and 
director of the Division of 
Radiation Sciences, as 
invited lecturer, presented 
the Special Lecture, "Recent 
Advances in Radiopharma- 
ceutical Development and 
Applications," at the 33rd 
Annual Meeting of the Japan- 
ese Society of Nuclear Medi- 
cine, Miyazaki, October 29. 
Anthony J. Wilson, M.D., 
associate professor and 
director of emergency radiol- 
ogy, spoke on "Digital Mus- 
culoskeletal Imaging" at the 
Refresher Course, 20th 
Annual International Skele- 
tal Society Meeting, Toronto, 
August 15 - 20. 
_ 






The following Mallinckrodt 
Institute staff members par- 
ticipated in the 35th Annual 
Meeting and Technical 
Exhibition of the American 
Association of Physicists in 
Medicine, Washington, D.C., 




James A. Purdy, Ph.D., 





Vivek Mishra, Ph.D.; Jef- 
frey F. Williamson, Ph.D.; 
Zuofeng Li, D.Sc; Ali 
Soleimani-Meigooni, 
Ph.D.; "RadioChromic Film 
Densitometry for High Dose 
Rate Ir-192 Dosimetry: 




Eric E. Klein, M.S.; Daniel 
A. Low, Ph.D.; Christo- 
pher Durbin, Ph.D.; James 
A. Purdy, Ph.D., "Changes 
in Electron Beam Dosimetry 
with the New Scattering Foil- 
Applicator Systems on a 
C12100C" 
Eric E. Klein, M.S.; Daniel 
A. Low, Ph.D.; Christo- 
pher Durbin, Ph.D.; Ali 
Soleimani-Meigooni, 
Ph.D.; James A. Purdy, 
Ph.D., "Dosimetry for Clini- 
cal Implementation of 




Ph.D.; Harish Panth, 
Ph.D.*; Vivek Mishra, 
Ph.D.; Jeffrey F. 
Williamson, Ph.D., "Depen- 
dence of Linearity, Accuracy, 
and Low-Dose Limit of TLD 
Response on Nitrogen Flow 




Ph.D.; Eric E. Klein, M.S.; 
Christopher Durbin, 
Ph.D.; James A. Purdy, 





Ph.D.; Eric E. Klein, M.S.; 
Vivek Mishra, Ph.D.; 
Daniel A. Low, Ph.D.; 
James A. Purdy, Ph.D., 
"GafChromic Film Dosimetry 
for Megavoltage X-ray 
Beams" 
Robert E. Drzymala, 
Ph.D.; Prithvi Narayan, 
M.S.*; Timothy R. O'Leary, 
M.D.; Keith M. Rich, M.D.*; 
Joseph R. Simpson, M.D.; 
Todd H. Wasserman, M.D.; 
William B. Harms, B.S.; 
John W. Matthews, D.Sc; 
James A. Purdy, Ph.D., "A 
Computerized Treatment 
Planning System for Stereo- 
tactic Radiosurgery." 
♦Department of Neurological 
Surgery, Washington Univer- 
sity, St. Louis 
Program 5 
Robert E. Drzymala, 
Ph.D.; Prithvi Narayan, 
M.S.*; Keith M. Rich, 
M.D.*, "A Computerized Sys- 
tem for Image-Based Plan- 
ning of Stereotactic Brain 
Biopsies." *Department of 
Neurological Surgery, Wash- 
ington University, St. Louis 
Walter R. Bosch, D.Sc; 
Daniel A. Low, Ph.D.; Rus- 
sell L. Gerber, M.S.; Mary 
L. Vogelsang Graham, 
M.D.; Jeff M. Michalski, 
M.D.; Carlos A. Perez, 
M.D.; James A. Purdy, 
Ph.D., "An Electronic View 
Box Tool for Radiaton Ther- 
apy Treatment Verification" 
Daniel A. Low, Ph.D.; Eric 
E. Klein, M.S.; Derek K. 
Maag, electronic techni- 
cian; James A. Purdy, 
Ph.D., "The Commissioning 
of a Varian PortalVision™ 
Electronic Portal Imaging 
Device" 
Program 6 
Zuofeng Li, D.Sc; Ali 
Soleimani-Meigooni, 
Ph.D.; Vivek Mishra, Ph.D., 
"A Comparative Study of 
Dosimetric Properties of 
Solid Water and Plastic 
Water in Brachytherapy 
Applications" 
Zuofeng Li, D.Sc; Jeffrey 
F. Williamson, Ph.D.; 
Harold Perera, Ph.D., 
"Monte Carlo Calculation of 
Kerma-to-a-Point Near Media 
Interfaces" 
Jeffrey F. Williamson, 
Ph.D., Zuofeng Li, D.Sc; 
Perry W. Grigsby, M.D.; 
"Monte Carlo Aided Dosime- 
try of the MicroSelection 
PDR Source and Shielded 
Fletcher Colpostat" 
Jeffrey F. Williamson, 
Ph.D.; Ali Soleimani-Mei- 
gooni, Ph.D.; Perry W. 
Grigsby, M.D.; Steven 
Teague*, "Acceptance Test- 
ing of a Novel Single-Step- 
ping Source Remote 
Afterloader for Low Dose- 





Jeffrey F. Williamson, 
Ph.D., cochairman 
Eduardo G. Moros, Ph.D.; 
Eric E. Klein, M.S.; 
William Straube, M.S.; 
Robert J. Myerson, M.D., 
"Clinical Systems for Simul- 
taneous Superficial Hyper- 
thermia and External Beam 
Radiation" 
Program 8 
Y. Abel Cheng, M.S.; 
William B. Harms, B.S.; 
Russell L. Gerber, M.S.; 
John W. Wong, Ph.D.*; 
James A. Purdy, Ph.D., "A 
Systematic Verification of a 
3-D Electron Beam Dose Cal- 
culation Algorithm." 
*Department of Radiation 
Oncology, William Beaumont 
Hospital, Royal Oak, 
Michigan 
Program 9 
Eric E. Klein, M.S.; James 
A. Purdy, Ph.D., "A Com 
prehensive Dosimetric and 
Continuing Quality Improve- 




Nilesh L. Jain, M.S.; 
Michael G. Kahn, M.D.*; 
James A. Purdy, Ph.D.; "A 
Decision-theoretic Model for 
the Objective Evaluation of 
3D Radiation Treatment 
Plans." *Department of 
Internal Medicine, Washing- 
ton University, St. Louis 






The following Mallinckrodt 
Institute staff members par- 
ticipated in the Tenth Inter- 
national Symposium on 
Radiopharmaceutical 
Chemistry, Kyoto, Japan, 






Dal Y. Chi, Ph.D.*; James 
P. O'Neil, Ph.D.*; Carolyn 
J. Anderson, Ph.D.; 
Michael J. Welch, Ph.D.; 
John A. Katzenellenbo- 
gen, Ph.D.*, "Novel Homo- 
and Heterodimeric Bis- 
bidentate (NS) Tech- 
netium(V) Complexes. An 
Approach to Metal Com- 
plexes that Mimic Steroid 
Hormones." '"Department of 





Timothy J. McCarthy, 
Ph.D.; Thomas A. 
: j Bonasera, M.S.; Michael J. 
' Welch, Ph.D.; Shlomo 
J j Rozen, Ph.D.*, "Application 
. I of Methyl Hypofluorite 
I Chemistry: Synthesis of 
. Novel Steroidal Substrates 
i and Labeling with C-ll." 
{ *School of Chemistry, Tel- 
Aviv University, Israel 
Poster Presentation 
Carmen S. Dence, M.S.; 
Christy S. John, Ph.D.; 
Michael J. Welch, Ph.D., 
"The Combined Use of 
Microwave Heating and Pho- 







Carmen S. Dence, M.S.; 
Michael J. Welch, Ph.D.; 
Barbara J. Hughey, Ph.D.*; 
Robert E. Klinkowstein, 
Ph.D.*; Ruth E. Shefer, 
Ph.D.*, "A New Method of 
Nitrogen-13 Ammonia Pro- 
duction Applicable with Low 
Energy Accelerator." *Sci- 






Michael J. Welch, Ph.D., 
chairman 
Carolyn J. Anderson, 
Ph.D.; Buck E. Rogers, 
M.S.; Judith M. Connett, 
Ph.D.*; Li W. Guo, Ph.D.; 
Sally W. Schwarz, R. Ph., 
M.S.; Kurt R. Zinn, D.V.M., 
Ph.D.**; Michael J. Welch, 
Ph.D., "Comparison of Two 
Bifunctional Chelates for 
Labeling 64 Cu to Mab 1A3 
and 1A3-F(ab')2: Chemistry 
and Animal Biodistribution." 
'"Department of Surgery, 
Washington University, St. 
Louis. **Research Reactor, 
University of Missouri, 
Columbia 
Poster Presentations 
Wilson B. Edwards, M.S.; 
Carolyn J. Anderson, 
Ph.D.; Michael J. Welch, 
Ph.D.; Cynthia G. Fields, 
M.S.*, "The Synthesis of 
DTPA-D-Phe1_octreotide by 
Solid-phase Synthesis." 
♦Department of Biomedical 
Engineering, University of 
Minnesota 
Carolyn J. Anderson, 
Ph.D.; Wilson B. Edwards, 
M.S.; Tammy S. Pajeau, 
M.S.; Buck E. Rogers, 
M.S.; Kurt R. Zinn, D.V.M., 
Ph.D.*; Henry V. Lee, B.A.; 
Michael J. Welch, Ph.D., 
"In vitro and in vivo Evalua- 
tion of [64 Cu-CPTA-D-Phe1]- 
octreotide: An Agent for 
Quantitating Somatostatin 
Receptors with PET." 
♦Research Reactor, Univer- 
sity of Missouri, Columbia 





Stephen M. Moerlein, 
Ph.D.; Joel S. Perlmutter, 
M.D.; James L. Bockhorst, 
B.S.; David Parkinson, 
Ph.D.*; Michael J. Welch, 
Ph.D., "N-Alkylated Ana- 
logues of [F-18]Benperidol 
as Dopaminergic D-2 Recep- 
tor Ligands." '"Department 
of Cell Biology and Physiol- 





Timothy J. McCarthy, 
Ph.D.; Michael J. Welch, 
Ph.D.; Jian Zhang, M.S., 
"Nitric Oxide Synthase 
(NOS): Approaches to the 
Design and Synthesis of 
Inhibitors of this Enzyme 
Suitable for Radiolabeling 
and Measurement of in vivo 
Biodistribution" 
Poster Presentations 
Carolyn J. Anderson, 
Ph.D.; Christy S. John, 
Ph.D.*; Robert K. Keast, 
CNMT; Henry V. Lee, B.A.; 
Michael J. Welch, Ph.D., 
"N,N'-Ethylene-di-L-cysteine: 
A Potential Ligand for Gal- 
lium and Indium Radiophar- 
maceuticals." '"Department 
of Radiology, George Wash- 
ington University, Washing- 
ton, D.C. 
Sally W. Schwarz, R.Ph., 
M.S.; John O. Eichling, 
Ph.D.; Michael J. Welch, 
Ph.D., "Considerations 
Necessary for Determining 





Barry A. Siegel, M.D., pro- 
fessor of radiology and med- 
icine, and director of the 
Division of Nuclear Medi- 
cine, is president of the 
Washington University Med- 
ical Center Alumni Associa- 
tion (WUMCAA). He earned 
both his undergraduate and 
medical degrees at Washing- 
ton University and has been 
an MIR faculty member and 
director of the Division of 
Nuclear Medicine since 
1973. 
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APPOINTMENTS/ 
ELECTIONS 
Jeffrey J. Brown, M.D., 
associate professor of radiol- 
ogy and chief of the magnetic 
resonance imaging section, 
was appointed director of the 
research residency at the 
Institute. 
Mary L. Vogelsang Graham, 
M.D., instructor in radiology, 
was appointed to the 1993- 
1994 Committee on Admis- 
sions, Washington University 
School of Medicine. 
Daniel A. Low, Ph.D., 
instructor in radiology, was 
appointed to full membership 
in the American Association 
of Physicists in Medicine. 
Bruce L. McClennan, M.D., 
professor of radiology and 
chief of the abdominal imag- 
ing section, will serve a two- 
year term as the elected fac- 
ulty representative to the 
Department of Radiology, 
Executive Committee. 
Ali Soleimani-Meigooni, 
Ph.D., assistant professor of 
radiology, was selected presi- 
dent-elect (1993-1994) of the 
Missouri Valley Chapter of 
the American Association of 
Physicists in Medicine. 
Michael W. Vannier, M.D., 
professor of radiology and 
director of the Division of 
Radiology Research, was 
named chairman of the Mis- 
souri State Medical Associa- 
tion's 1993-1994 Commission 
on Continuing Education and 
Health Manpower. 
ALUMNI NEWS 
When Phyllis Isbell, R.T., retired after 38 years at the Washington University Medi 
Center, (left to right) doctors Jerry Palagallo, MIR 74; Art Bishop, '81; Tom Getz, 
'87; and Bill Berkman, 79, couldn't make it to the retirement party. So, the fourso 
from Methodist Medical Center of Illinois in Peoria donned fluoro gear and had this 
special photograph made for Phyllis' memory book. 
Residents, trainees, and fellows for 1992-1993 were (front row, left to right) Doctors Neda Yagon; L. Santiago Medina; Colin P. Derdeyn; Scott M. Baker, chief resident; 
Ronald G. Evens, director of the Institute; Allen B. Oser, cochief resident; James R. Duncan; Neal A. Frenkel; Jeffrey A. Friedland; Andrew J. Fisher; Mary G. Alderman; (second 
row, left to right) Eric R. Weidman; Michele D. Semin; Kyongtae Tyler Bae; Valerie Christy Rekhert; Lane A. Deyoe; Paul S. Hsieh; Maria E. Schmidt; Cynthia Karfias-Rigsby; 
Anthony M. Foti; Matthew J. Fleishman; Richard N. Edelstein; (third row, left to right) Michael C. Roarke; Eric S. Maiden; Howard P. Forman; Meredith W. Bell; Robin Frank- 
Gersiberg; Spencer M. Smith; Benjamin J. Bartnicke; Hamid R. Lotifi; Shawn P. Quillin; Farrel K. VanWagenen; (back row, left to right) Chi-Lai Ho; Rosalie J. Hagge; Francis J. 
Schlueter; Linda R. King; Dale P. Harris; James D. Matthews* Constance M. Courtois- Patrick 0 Gordon* M Gena Frederick- Mark *> 7nd--l- r     J U p       r     n i L 
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COST CONTAINMENT AND 
TECHNOLOGY ASSESSMENT: 
SCIENTIFIC CHALLENGES 
The cost of medical care has 
increased at a rate greater than 
the increase in the gross national 
product of the United States. Until 
now, medicine has been relatively 
immune to cost considerations. At 
some point, strenuous efforts to con- 
tain costs will necessarily be made 
and will be shaped by social, political 
and scientific forces. This review 
will discuss technology assessment 
and the scientific challenges that 
need to be addressed in an era of 
cost containment. 
Concerns about costs have 
increased the demand for scientific 
evidence to show that a diagnostic 
test (as well as therapeutic interven- 
tions) benefits patients in some 
meaningful way. In the past, tech- 
nology assessment focused on diag- 
nostic accuracy. In the future, 
technology assessment will be 
focused on whether or not use of 
the technology improves patient 
outcome. 
The Agency for Health Care Pol- 
icy and Research (AHCPR) is a new 
federal agency created to encourage 
patient outcome research. The 
REFLECTIONS 
by Henry D. Royal, M.D. 
AHCPR was instrumental in the 
development of "Practice Guidelines" 
that recommend how to best manage 
patients with various diseases. 
TECHNOLOGY ASSESSMENT 
Technology assessment is one of 
many factors considered when 
developing a practice guideline and 
can focus on many different levels of 
efficacy (Table 1). These levels of 
efficacy have a natural hierarchy. 
Demonstration that a technology is 
"better" at a lower level of efficacy is 
a necessary but insufficient require- 
ment to demonstrate that the tech- 
nology is "better" at a higher level of 
efficacy. 
The lowest level of efficacy mea- 
sures the technical characteristics of 
the technology. For example, one 
type of computed tomography (CT) 
scanner may have better spatial res- 
olution that another type of CT 
scanner. This technical advantage 
does not necessarily translate into 
better diagnostic accuracy, better 
patient management, or better 
patient outcome. 
The next higher level of efficacy 
measures diagnostic accuracy. The 
most rudimentary study of diagnostic 
accuracy describes the findings in 








Level Example This initial 
1. Technical Characteristics Spatial Resolution assessment 
simply deter- 
2. Diagnostic Accuracy 
Descriptive Findings in normals/abnormals 
whether or 
Quantitative Sensitivity/specificity not further l' ROC Curve assessment 
Likelihood Ratio of the tech- 
! 3. Diagnostic Certainty 
Post-test probability nology 
should be 
4. Patient Management Treatment changed because pursued. 
of test result Unfortu- 
5. Patient Outcome Patient outcome changed nately, these 
due to change in treatment preliminary 
assessments 
6. Societal Outcome Cost/Benefit are often 
misconstrued as indicating that the 
technology is clinically useful. 
The accuracy of a test in differ- 
entiating normal from abnormal 
patients is expressed traditionally as 
the sensitivity and specificity. Unlike 
overall accuracy, these measures are 
independent of disease prevalence 
and, therefore, are a better measure 
of diagnostic accuracy. Despite their 
widespread use, sensitivity and 
specificity have a number of glaring 
deficiencies. First, the researcher is 
forced to reduce the results of a 
complex imaging test that displays 
many features to a binary result (nor- 
mal or abnormal). This data reduc- 
tion makes subsequent data analysis 
much simpler; however, the obvious 
drawback is that significant informa- 
tion from the test is ignored. 
Second, the disease status of the 
patient also is reduced to a binary 
result. This oversimplification does 
not permit evaluation of test perfor- 
mance with disease severity. In addi- 
tion, disease status is often 
determined by another imperfect test 
and does not necessarily represent 
the true disease status of the patient. 
Third, sensitivity and specificity 
rarely are reported with 95 percent 
confidence intervals. This omission 
hides the fact that sensitivity and 
specificity measurements often are 
inexact simply due to the small num- 
ber of subjects used to measure 
these two parameters. 
Receiver operator characteristic 
(ROC) curves address some of the 
deficiencies of sensitivity and speci- 
ficity. These curves traditionally 
classify the test result in one of five 
categories: definitely normal, proba- 
bly normal, possibly abnormal, prob- 
ably abnormal, and definitely 
abnormal. Four sensitivity, speci- 
ficity pairs can be created by using a 
different threshold for distinguishing 
normal from abnormal test results. 
For example, a strict threshold 
would require that the test result be 
classified as "definitely abnormal" in 
order to be considered "abnormal," 
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REFLECTIONS 
continued from page 31 
Table 2 
Calculation of Likelihood Ratios 
Probability of a Test Feature 
vs Disease Status 
D+ D- LR 
T1 .5 .005 100 












Tn = Individual Test Feature 
D+ = Disease Population 
D- = Nondisease Population 
LR = Likelihood Ratio 
resulting in the lowest sensitivity but 
the highest specificity. On the other 
hand, a lax threshold would classify 
all test results other than "definitely 
normal" as "abnormal," resulting in 
the highest sensitivity but the lowest 
specificity. Typically, the ROC curve 
is plotted as the sensitivity versus 
one minus the specificity. As test 
performance improves, the curve is 
shifted upward and to the left. 
The final, and probably the best, 
way to express the diagnostic accu- 
racy of a complex test is likelihood 
ratios. A detailed list of the potential 
features in an image is generated, 
e.g., the size of a lung nodule, 
whether its borders are smooth or ill 
defined, whether it is calcified, etc. 
How often these features are present 
in the disease of interest (e.g., malig- 
nant lung tumors) is compared to an 
appropriate "non-disease" group 
(patients with benign lung nodules) 
(Table 2). The likelihood ratio is cal- 
culated simply by dividing the proba- 
bility of finding that particular test 
feature in patients with disease by 
the probability of finding that identi- 
cal test feature in patients without 
the disease. If the likelihood ratio for 
a particular test feature is 
■ much greater than 
1.0 (the feature is much 
more common in patients 
with the disease than 
without the disease), the 
feature greatly increases 
the chances that the 
patient has the disease; 
■ equal to one, that 
test feature does not help 
distinguish patients with 
and without the disease 
of interest; 
■ much less than one, 
that test feature is useful 
for excluding the disease. 
When test features 
are listed with their likeli- 
hood ratios, it becomes 
very apparent which 
features of an image 
have the most diagnostic value. 
The likelihood ratios can be deter- 
mined not only for the individual test 
features but also for combinations 
of test features. 
SCIENTIFIC CHALLENGES 
In order to improve the cost-effec- 
tive use of diagnostic tests, the 
emphasis of technology assessment 
must change. Multicenter studies to 
determine how a diagnostic test 
changes patient outcomes will be 
necessary. For example, patients 
may be randomized into one group of 
patients having the diagnostic test 
and another group not having the 
diagnostic test. Measures of morbid- 
ity, mortality, patient preferences and 
satisfaction would be obtained in 
each group to determine the impact 
of introducing the new test. 
In the past we have measured the 
efficacy of a test, in the future we will 
measure the effectiveness of the test. 
Efficacy is measured by using a 
homogeneous well-defined patient 
population; the test is performed and 
interpreted in an ideal setting by 
experts in the field. Effectiveness 
would determine how well the test 
performs in a more realistic clinical 
setting. The impact of the test would 
be determined in multiple medical 
centers to determine if the perfor- 
mance of the test is greatly reduced 
in a more realistic clinical setting. 
The development of more sensi- 
tive diagnostic tests may lead to 
some unexpected problems. First, 
the prognostic value of a test may 
decrease because everyone with the 
disease now has a positive test 
rather than just the most severely 
affected. Second, the apparent 
prevalence of disease increases. A 
good example of this problem is 
prostate cancer. Since clinically 
occult and insignificant disease is 
common, better diagnostic tests will 
increase the apparent prevalence of 
this disease. Third, the diagnosis of 
clinically insignificant disease will 
falsely increase our perceptions of 
the apparent efficacy of treatment. 
Patients whose disease would never 
have harmed them will now be 
regarded as cures. 
The demand that medicine be 
more scientific and evidence-based 
is laudable. In the future, it will be 
a challenge to maintain the appro- 
priate balance between the science 
and art of medicine. Scientists are 
better able to accumulate scientific 
evidence than are physicians. In 
order to understand pathophysio- 
logic mechanisms, scientists can 
study inbred animals (in order to 
minimize confounding variables) 
and they can perform interventions 
that would be unethical in humans. 
Because of the limitations imposed 
when studying human disease, we 
must accept the fact that the sci- 
ence of medicine will always be 
flawed. If the demand for scientific 
evidence in medicine is too great, 
innovation will be greatly slowed 
and future patients will suffer. □ 
Dr. Royal is professor of radiology and 
associate director of the Division of 
Nuclear Medicine.  This article origi- 
nally appeared in the September issue 
of MIR Update, a physician newsletter 
distributed quarterly by the Institute. 
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As the guest of 
Washington University 
and Friends of Tibet, 
the 14th Dalai Lama 
of Tibet, His Holiness 
Tenzin Gyatso, was in 
St. Louis in September. 
His Holiness made a 
special visit to the 
Institute's seventh- 
floor positron emission 
tomography (PET) facility 
to learn more about the 
work of Marcus E. Raichle, 
M.D., professor of radiol- 
ogy and neurology and 
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